Transcripta Bio: Series AAI-powered drug discovery company developing treatments for neurological and neuromuscular diseasesOct 4, 2026RoundOSTranscripta BioCompany profile and funding historySourcesbusinesswire.comMore in BiotechAusperBio · Series CProFound Therapeutics · StrategicTransfyr · SeedAISeries A · AIBiotechUnited StatesNorth AmericaSeries A